Israel Performs First Alpha Radiation Treatment on Recurrent Brain Tumor Patient
How 3 Israeli newsrooms covered this story — translated into English and compared side by side.
First reported by Mako · 1 day ago
What happened
Hadassah Medical Center in Israel treated a 77-year-old man with recurrent glioblastoma using Alpha DaRT, a novel alpha radiation therapy implanting tiny radiation sources directly into the tumor. This first-in-Israel procedure aims to precisely target tumors while sparing healthy brain tissue and is part of a Phase I clinical trial assessing safety and feasibility. The treatment follows extensive research collaboration and may offer new hope for glioblastoma patients with limited options.
- 01A 77-year-old man with recurrent glioblastoma received Israel's first Alpha DaRT alpha radiation treatment.
- 02The procedure implanted tiny alpha radiation sources into the brain tumor via two simultaneous trajectories for precision.
- 03The Phase I clinical trial at Hadassah Medical Center tests the treatment's safety and feasibility in recurrent glioblastoma.
- 04Glioblastoma is the most common malignant adult brain tumor with poor prognosis and limited recurrent treatment options.
- 05Preclinical data suggest alpha radiation may also trigger immune responses against tumors elsewhere in the brain.
- 06Hadassah plans to expand trials to brain metastases unresponsive to surgery or stereotactic radiosurgery.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 3 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
